Skip to content

A Comparative Study on Type 2 Diabetes Mellitus

A Comparative Study on Asanadi Yoga with Shalvarga and Metformin on Sthula Madhumeha with special reference to Type 2 Diabetes Mellitus specifically on HbA1c and Lipid Profile

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/06/014635
Enrollment
68
Registered
2018-06-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- with controlled systemic disorders

Interventions

Intervention1: Asanadi Yoga with Shalvarga: Churna of Asanadi Yoga with Drugs of Shalvarga will give 5gm twice in a day with luke warm water before meal for 3months. Contents of drug-Asan(vijaysar),Sh

Sponsors

Shweta Ramesh Aswar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient having fasting plasma glucose level 126mg/dl to 200mg/dl and post prandial plasma glucose level 200mg/dl to250mg/dl. 2. HbA1c is 6.5% up to 8.5%. (In standardised assay, the HbA1c approximates the estimated average glucose value according to ADAG formula (A1c Derivated Average Glucose Level) that is 140mg/dl to197mg/dl[29] 3. Patients fulfilling criteria of diagnosis and having clinical features of Sthula Madhumeha (Diabetes Mellitus) 4.Patients having BMI more than 23Kg/m2 up to 30Kg/m2 will be selected. 5.Those are willing to participate in trial and ready to give written consent. 6.Patients with controlled Hypertension.

Exclusion criteria

Exclusion criteria: 1.Patients who already taken anti Diabetic drugs. 2.Patients having Insulin Dependent Diabetes Mellitus and Juvenile Diabetes and various other types of Diabetes except Type II DM 3.Patients having complications such as vasculopathy, nephropathy, retinopathy and neuropathy. 4.Patients having other systemic complications like hepatic, renal and cardiac problems. 5.Pregnant and lactating females not included in this study. 6.Patients who are currently participating in any other clinical trials since last 6 months.

Design outcomes

Primary

MeasureTime frame
1.To evaluate the effect of Asanadi Yoga on clinical features of Sthula Madhumeha and specifically on BMI, Waist/hip ratio, Lipid profile , plasma glucose level fasting and post prandial and HbA1c. 2. To evaluate the effect of Metformin on clinical features of Sthula Madhumeha and specifically on BMI, Waist/hip ratio, Lipid profile and plasma glucose level fasting and post prandial and HbA1c. Timepoint: 1) On Zero Day i.e.B.T.value 2) In trial group Asanadi Yoga with Shalvarga 5gm twice a day and in control group Tablet Metformin 500mg twice a day will be given to the patients for 3months. 3) Follow up and assessment will be done on every 15days after starting medicine upto 90days. 4) Final assessment will be done on 90thday.

Secondary

MeasureTime frame
1.To study the literature of Madhumeha as per Ayurvedic perspective. 2.To study the literature of Diabetes Mellitus in modern point of view. Timepoint: 18months

Countries

India

Contacts

Public ContactSushil Vilas Chawre

Govt.Ayurved College,Nagpur

sushilvilaschawre@gmail.com9923755771

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026